NASDAQ: MYGNMyriad Genetics Revenue
Myriad Genetics revenue was $831.30M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $195.9M, down 7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MYGN annual revenue was $837.6M, with 11.2% growth year-over-year.
MYGN past revenue growth
How has MYGN's revenue growth performed historically?
Company
7.38%
Industry
4.49%
Market
34.96%
MYGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MYGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MYGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
MYGN revenue history
Current Revenue
$831.3M
Current Earnings
-$101.4M
Current Profit Margin
-12.2%
Be the first to know when MYGN announces revenue.
MYGN Revenue History By Year
| MYGN Yearly Revenue | MYGN Revenue | MYGN Change | MYGN Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $837.60M | $84.40M | +11.21% |
| 2023-12-31 | $753.20M | $74.80M | +11.03% |
| 2022-12-31 | $678.40M | -$12.20M | -1.77% |
| 2021-12-31 | $690.60M | $52.00M | +8.14% |
| 2020-06-30 | $638.60M | -$212.50M | -24.97% |
| 2019-06-30 | $851.10M | $107.40M | +14.44% |
| 2018-06-30 | $743.70M | $15.00M | +2.06% |
| 2017-06-30 | $728.70M | -$11.80M | -1.59% |
| 2016-06-30 | $740.50M | $17.40M | +2.41% |
| 2015-06-30 | $723.10M | -$55.10M | -7.08% |
| 2014-06-30 | $778.20M | $165.00M | +26.91% |
| 2013-06-30 | $613.20M | $117.20M | +23.63% |
| 2012-06-30 | $496.01M | $93.92M | +23.36% |
| 2011-06-30 | $402.08M | $39.44M | +10.87% |
| 2010-06-30 | $362.65M | $36.12M | +11.06% |
| 2009-06-30 | $326.53M | $103.67M | +46.52% |
| 2008-06-30 | $222.86M | $77.57M | +53.39% |
| 2007-06-30 | $145.29M | $31.01M | +27.13% |
| 2006-06-30 | $114.28M | $31.87M | +38.68% |
| 2005-06-30 | $82.41M | $25.76M | +45.47% |
| 2004-06-30 | $56.65M | -$7.67M | -11.93% |
| 2003-06-30 | $64.32M | $10.49M | +19.48% |
| 2002-06-30 | $53.84M | $8.67M | +19.21% |
| 2001-06-30 | $45.16M | $11.15M | +32.78% |
| 2000-06-30 | $34.01M | $8.70M | +34.37% |
| 1999-06-30 | $25.31M | $2.10M | +9.06% |
| 1998-06-30 | $23.21M | $7.97M | +52.34% |
| 1997-06-30 | $15.24M | $8.61M | +129.85% |
| 1996-06-30 | $6.63M | $5.33M | +412.06% |
| 1995-06-30 | $1.29M | N/A | N/A |
Myriad Genetics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.